SCHEMBL13530692

SCHEMBL13530692

CC(C)(C)NC(=O)Nc1nc(O)ncc1F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 18/20 0.45
SRC P12931 11/20 0.45
PDGFRB P09619 10/20 0.45
PDGFRA P16234 10/20 0.45
HTT P42858 1/20 0.41
EGFR P00533 5/20 0.39
FGFR2 P21802 5/20 0.39
FGFR4 P22455 5/20 0.39
FGFR3 P22607 5/20 0.39
KDM4E B2RXH2 1/20 0.38
NPC1 O15118 1/20 0.38
ALDH1A1 P00352 1/20 0.38
TP53 P04637 1/20 0.38
GAA P10253 1/20 0.38
HPGD P15428 1/20 0.38
CASP1 P29466 1/20 0.38
RAB9A P51151 1/20 0.38
CASP7 P55210 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13476071 0.81 SYK (0.47) HTTKDM4EALDH1A1GAAHPGD
SCHEMBL1225015 0.79 AURKA (0.37) EGFRKDM4EGAA
SCHEMBL13530680 0.79 AURKA (0.43) GAAHSD17B10MAPK1
SCHEMBL13530696 0.77 AURKA (0.45) NPC1ALDH1A1RAB9ASMN1; SMN2MAPK1
SCHEMBL13383587 0.76 AURKA (0.37) ALDH1A1MAPK1
SCHEMBL13530676 0.75 RAB9A (0.51) HTTKDM4ENPC1ALDH1A1TP53
SCHEMBL13383572 0.75 SMN1; SMN2 (0.43) KDM4EALDH1A1RAB9ASMN1; SMN2HSD17B10
SCHEMBL13383266 0.75 ADORA3 (0.40) KDM4ENPC1ALDH1A1HPGDRAB9A
SCHEMBL1270948 0.75 SMN1; SMN2 (0.50) FGFR1SRCHTTFGFR3NPC1
SCHEMBL13530861 0.74 AURKA (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9204653-B2 5-fluoro pyrimidine derivatives DOW AGROSCIENCES LLC (US) 2015-12-08 US disclosed
US-9204653-B2 5-fluoro pyrimidine derivatives DOW AGROSCIENCES LLC (US) 2015-12-08 US disclosed
US-20140024616-A1 5-FLUORO PYRIMIDINE DERIVATIVES DOW AGROSCIENCES LLC (US) 2014-01-23 US disclosed
US-20140024616-A1 5-FLUORO PYRIMIDINE DERIVATIVES DOW AGROSCIENCES LLC (US) 2014-01-23 US disclosed
US-20100022538-A1 5-FLUORO PYRIMIDINE DERIVATIVES DOW AGROSCIENCES LLC (US) 2010-01-28 US disclosed
US-20100022538-A1 5-FLUORO PYRIMIDINE DERIVATIVES DOW AGROSCIENCES LLC (US) 2010-01-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100022538-A1 5-FLUORO PYRIMIDINE DERIVATIVES DPYD, DPM1, DDX5 FGFR1 2405/4885SRC 1727/4885PDGFRB 1313/4885
US-20140024616-A1 5-FLUORO PYRIMIDINE DERIVATIVES DPYD, DPM1, DDX5 FGFR1 2405/4885SRC 1727/4885PDGFRB 1313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.